Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by hesuveron Jan 10, 2012 11:05pm
332 Views
Post# 19389642

RE: RE: RE: RE: RE: new corporate presentation

RE: RE: RE: RE: RE: new corporate presentation

Scottie I sent two private messages to thian asking for an explanation regarding the statement he made regarding the B2Gold rumor.  He is yet to reply.

 

I was not aware of the fact (my fault I admit) that Barry Rayment is on both the B2Gold and Golden Predator boards.  Now I am wondering if anything is happening and indeed if there are secret negotiations between these two companies.  I know that B2Gold is hungry for "gold in the ground" and I do not want us to become a victim to them.  I entered GPD at 1.05$ and I will not agree to anything that will not give me a healthy premium on my initial investment.

 

Be honest with me, have you heard anything about a joint venture (JV) or takeover.  I would prefer if you do not answer that question if the answer is going to be an untruth.  We are here to assist each other.  Thian made a bold statement and has gone quiet now. 

 

Attention Thian!  Its time to man up now!  You are responsible for your posts. 

Thian Posted the following:

RE: new corporate presentation
Actually rumors has it that B2Gold is in negotiations with Golden Predator.
 
I corrected your bad spelling.  This is the link:

 

Bullboard Posts